OAM
CATX icon

Oxford Asset Management’s Perspective Therapeutics CATX Stock Holding History

Oxford Asset Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,805
Closed -$31.5K – 556
2025
Q1 		$31.5K Buy
14,805
+4,730
+47% +$14.2K 0.01% 460
2024
Q4 		$32.1K Sell
10,075
-3,197
-24% -$26.1K 0.01% 433
2024
Q3 		$177K Buy
+13,272
New +$177K 0.15% 254

Other funds holding CATX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $170M AUM 10.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Oxford Asset Management's CATX Position: Q2 2025 in Review

Oxford Asset Management sold out of Perspective Therapeutics (CATX) in Q2 2025, closing a stake of 14,805 shares — an estimated $31.5K sold.

Oxford Asset Management first reported a position in CATX in Q3 2024 and held it in 3 quarters. The position peaked at $177K in Q3 2024. 97 funds tracked by Wall St. Rank hold CATX as of Q2 2025.

  • Oxford Asset Management reported no remaining Perspective Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Oxford Asset Management sold 14,805 Perspective Therapeutics shares in Q2 2025, an estimated $31.5K.
  • Oxford Asset Management first reported a position in Perspective Therapeutics in Q3 2024 and held it in 3 quarters.
  • Oxford Asset Management's Perspective Therapeutics position peaked at $177K in Q3 2024.
  • 97 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2025.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.